INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare lung disease: experimental drug targets immune overdrive
Disease control Not yet recruitingThis study tests a drug called emapalumab in 5 adults with a rare, fast-worsening lung disease caused by MDA5 antibodies. The drug aims to calm an overactive immune system to improve breathing and reduce the need for extra oxygen. Participants must have worsening lung function an…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
New hope for rare genetic lung disease: triple therapy trial launches
Disease control Not yet recruitingThis study tests whether a combination of three drugs (prednisone, azithromycin, and hydroxychloroquine) can slow lung function decline in adults with interstitial lung disease caused by specific gene variants. About 30 participants will receive either the triple therapy or stand…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Cord blood stem cells take on lung disease
Disease control Not yet recruitingThis early-stage study tests whether injecting stem cells from donated umbilical cords is safe for people with interstitial lung disease, a condition that scars the lungs and makes breathing hard. About 24 adults will receive the treatment to find the safest dose and check for an…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
New hope for lung disease patients: inhaled drug shows promise in long-term safety trial
Disease control Not yet recruitingThis study looks at the long-term safety of an inhaled medication called treprostinil palmitil inhalation powder (TPIP) for people with pulmonary hypertension caused by interstitial lung disease. About 344 adults who finished a previous study will take the drug and be monitored f…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New PET probe could spot lung scarring early
Diagnosis Not yet recruitingThis study tests a new type of PET scan that uses a special probe to find a protein called DDR2, which is linked to lung scarring in interstitial lung disease. The goal is to see if this scan can diagnose the disease earlier and more accurately than current methods. The study wil…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 20, 2026 11:56 UTC
-
Can custom oxygen boost daily steps for lung patients?
Symptom relief Not yet recruitingThis study looks at whether portable oxygen therapy, adjusted to each person's needs, helps people with chronic lung diseases like ILD and COPD be more active and feel better in daily life. Twenty-four adults who only have low oxygen when walking or exercising will try two types …
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated May 26, 2026 06:02 UTC
-
Smart oxygen device could free lung patients from constant monitoring
Symptom relief Not yet recruitingThis study tests a new device called MoblO2 that automatically adjusts oxygen levels for people with COPD or interstitial lung disease who need supplemental oxygen. Instead of constantly checking and adjusting their oxygen flow, users set a maximum level and the device keeps thei…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: National Jewish Health • Aim: Symptom relief
Last updated May 26, 2026 05:49 UTC
-
Home workouts may boost heart and lung function in rare disease
Symptom relief Not yet recruitingThis study looks at whether a 16-week home exercise program can improve how well the heart and lungs work in people with pulmonary hypertension linked to interstitial lung disease. About 30 adults will follow a structured exercise plan at home, and researchers will measure change…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC
-
Video games could be the key to easier breathing for lung disease patients
Symptom relief Not yet recruitingThis study will test whether playing active video games as part of a pulmonary rehab program can improve breathing and exercise ability in 42 adults with mild-to-moderate interstitial lung disease. Participants will be split into two groups: one doing video game-based exercises a…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Istinye University • Aim: Symptom relief
Last updated May 18, 2026 12:07 UTC